2011 Conference Programme

 

 

Conference Hours:

23-24 February 2011
9.30 - 16.30

 

Download the 2011 Conference Brochure

Download the 2011
Conference Brochure

Day 1
Day 2

 

 

Day 1 – Wednesday 23 February 2011

 

9.30 - 15.00
   
Moderator:
Dr. Yves Th. Tillet, CEO, WHITE-TILLET Consultants & Experts
Faraj Abdelnour, President of ACIDIM, Senior Consultant Europe, Quintiles Consulting
9:30-12:00
Keynotes from Competent Organisations:
S1-1
Opening Address
  Dr. Yves Th. Tillet, CEO, WHITE-TILLET Consultants & Experts
S1-2
Regulatory update in France
  Stephane Palies, Referent for innovation, AFSSAPS
10:20 – 10:40
Coffee break, visit the exhibition
S1-3
Regulatory update in UK
  Elizabeth Baker, Group Manager Licensing, MHRA
S1-4
Regulatory update in USA
  Jill Hartzler Warner, J. D., Acting Associate Commissioner for Special Medical Programs, US FDA
11:30 Panel Discussion
12:00
Networking lunch in the exhibition area
13:45 – 15:00
Keynotes from Notified Bodies
S1-5 Experience from French Notify Body
  Dr. Thierry Thomas, Head of Certification G-MED, LNE
S1-6 Experience from British Notify Body
  Theresa Jeary, Certification Manager, BSI Healthcare
S1-7 Experience from German Notify Body
  Dr. Wilma Hartung, General Manager Medical/Business Division Products, TÜV Rheinland LGA Products GmbH
15:00-15:15
Coffee break, visit the exhibition
15.15 – 16.30    
Moderator:
Faraj Abdelnour, President of ACIDIM, Senior Consultant Europe, Quintiles Consulting
Dr. Yves Th. Tillet, CEO, WHITE-TILLET Consultants & Experts
S2-1 Case study from a pharmaceutical company (10’)
  Speaker coming
S2-2 Case study from a medical company (10’)
  Speaker coming
S2-3 Experience from a contract R&D Organisation (10’)
  Prof. Dr. Markus Veit, CEO, i.DRAS GmbH
15:40 Panel discussion with:
  Dr. Yves Th. Tillet (WHITE-TILLET Consultants & Experts)
Stephane Palies (AFSSAPS)
Elizabeth Baker (MHRA)
Jill Hartzler Warner (US FDA)
Dr. Thierry Thomas (LNE)
Theresa Jeary (BSI Healthcare)
  Dr. Wilma Hartung (TÜV Rheinland LGA Products GmbH)
We invite you to submit questions for the speakers from competent organisations and notify bodies by 15th December to qiaoli.vrinat@ubm.com

 

 

 

Day 2 – Thursday 24 February 2011

 

9:30 – 12:00
Moderator:
Frank Richter, Head of Quality & Risk Management for Medical Devices, Sanofi-Aventis Deutschland GmbH
Prof. Dr. Markus Veit, CEO, i.DRAS GmbH
S3-1
Commercializing drug device combination products - future perspectives
  Crispin Simon, CEO, Biocompatibles UK Ltd
S3-2
Overview of Injectable Drug Devices for Self-Administration Including Pens, Auto-Injectors and New Patch-Injector/Pump Devices
  Ian Thompson, Head of Business Development, Delivery Systems,
Ypsomed AG
S3-3
Recent Advances in Transdermal Delivery of Biologics
  Steven P. Damon, Senior Vice President, Business Development, Altea Therapeutics
10:55 – 11:10
Coffee break, visit the exhibition
S3-4
Targeted Drug Delivery to the Central Nervous System (Brain and Spinal Cord)
  Prof. K.K. Jain M. D, CEO, Jain PharmaBiotech
S3-5
Combination of Diagnostics and Therapeutics
  Prof. K.K. Jain M. D, CEO, Jain PharmaBiotech
12:00 – 13:30
Networking lunch in the exhibition area
13:30 –16:10
 
Moderator:
Prof. Frederic Hildebrand, Research Director, Biomaterial Research Group,
Inserm Lille
Crispin Simon, CEO, Biocompatibles UK Ltd
S4-1 Significance of multi-responsive microgels for biomedical applications
  Muhammad Zafar, Research Scholar, University of Bolton
S4-2 A bioabsorbable product, providing the controlled release of local anesthetics to minimize postoperative pain
  Dr. Edouard Pelissier, Scientific Advisor, Statice Sante
S4-3 Biomedical textiles in implantable medical devices
  Jeffrey M. Koslosky, Director of Technology & Product Development, Secant Medical LLC, USA
S4-4 Peritoneal implants with controlled release of therapeutic molecules
  Dr. Nicolas Blanchemain, Assistant professor, Biomaterial Research Unity, Inserm Lille
S4-5 Bioceramics as Drug Carriers for Controlled-Release Technology
  Dr. Xiang Zhang, Principal Consultant, Medical Materials/Devices, CERAM
S4-6 Cost-effective nano-coating protection of medical devices (protein resistance, anti-microbial)
  Dr. Delwyn Evans, Principal Chemist, P2i